Noxilizer News

Investment accelerates global adoption of Noxilizer’s terminal sterilization alternative that is validated, safe, scalable and sustainable for biopharmaceutical and medical device manufacturers | Hanover, Maryland — September 10, 2025 — Noxilizer, Inc. (“Noxilizer”), the leader in […]

This month, a Noxilizer customer received authorization from EMA for their biotech drug in a prefilled syringe using NO2 sterilization. This follows the first FDA approval in 2024. There are other biotech drug submissions being reviewed at […]

The FDA recently approved a combination product using Noxilizer’s NO2 sterilization process. This is a biotech drug delivered in a prefilled syringe. The biotech company chose NO2 over other sterilization methods because of the ultra-low temperature sterilization process, […]